Sherrie and Alan Conover Center for Liver Disease & Transplantation

Research output

Research output per year 1983 2020 2021 2022 2023 2024

• 51859 Citations
• 913 Article
• 156 Review article
• 54 Comment/debate
• 42 Editorial
• 83 More
  • 28 Chapter
  • 25 Letter
  • 9 Other contribution
  • 8 Short survey
  • 4 Meeting Abstract
  • 3 Book
  • 3 Patent
  • 1 Scholarly edition
  • 1 Foreword/postscript
  • 1 Chapter (peer-reviewed)

Research output per year

Research output per year

Search results

• 2024

  A global action agenda for turning the tide on fatty liver disease

  Healthy Livers, Healthy Lives Collaborators, Feb 1 2024, In: Hepatology. 79, 2, p. 502-523 22 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fatty Liver 100%
  • Liver Diseases 78%
  • Public Policy 34%
  • Public Health 33%
  • Health Policy 31%
  6 Scopus citations

• A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

  Alkhouri, N., Edwards, K., Berman, M., Finn, H., Escandon, R., Lupinacci, P., Guthrie, N., Coste, A., Topete, J. & Noureddin, M., Jan 2024, In: Gastro Hep Advances. 3, 1, p. 9-16 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Liver Diseases 100%
  • Prescriptions 99%
  • Protons 90%
  • Fats 89%
  • Fatty Liver 63%

• Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21)

  Adelman, M. W., Connor, A. A., Hsu, E., Saharia, A., Mobley, C. M., Victor, D. W., Hobeika, M. J., Lin, J., Grimes, K. A., Ramos, E., Pedroza, C., Brombosz, E. W., Ghobrial, R. M. & Arias, C. A., Feb 1 2024, In: JAC-Antimicrobial Resistance. 6, 1, 158.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Organ Transplantation 100%
  • Epidemiology 72%
  • Infections 44%
  • Transplants 40%
  • Liver Transplantation 25%

• CD4⁺ T cell immunity is dependent on an intrinsic stem-like program

  Zou, D., Yin, Z., Yi, S. G., Wang, G., Guo, Y., Xiao, X., Li, S., Zhang, X., Gonzalez, N. M., Minze, L. J., Wang, L., Wong, S. T. C., Osama Gaber, A., Ghobrial, R. M., Li, X. C. & Chen, W., Jan 2024, In: Nature immunology. 25, 1, p. 66-76 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunity 100%
  • T-Lymphocytes 75%
  • Allografts 35%
  • Single-Cell Analysis 27%
  • Isoantigens 24%
  2 Scopus citations

• COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

  Kaur, B., Yeo, Y. H., Liang, J., Luu, M., Ayoub, W., Kuo, A., Trivedi, H., Sankar, K., Gong, J., Hendifar, A., Osipov, A., Kosari, K., Nissen, N., Noureddin, M., Singal, A. G. & Yang, J. D., Jan 2024, In: Gastro Hep Advances. 3, 2, p. 230-237 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Pandemics 84%
  • Hepatocellular Carcinoma 63%
  • Therapeutics 13%
  • Neoplasms 12%

• Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing

  REIMAGINE Study Group, Feb 2024, In: Clinical Gastroenterology and Hepatology. 22, 2, p. 259-270 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stem Cells 100%
  • Klebsiella 71%
  • Escherichia 40%
  • Hydrogen Sulfide 39%
  • Hydrogen 34%
  7 Scopus citations

• Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort

  Chang, M., Chang, D., Kodali, S., Harrison, S. A., Ghobrial, M., Alkhouri, N. & Noureddin, M., 2024, (Accepted/In press) In: Clinical Gastroenterology and Hepatology.

  Research output: Contribution to journal › Article › peer-review

  • Elasticity Imaging Techniques 100%
  • Fibrosis 61%
  • Guidelines 52%
  • Liver Diseases 34%
  • Population 32%

• Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis

  Harrison, S. A., Ratziu, V., Anstee, Q. M., Noureddin, M., Sanyal, A. J., Schattenberg, J. M., Bedossa, P., Bashir, M. R., Schneider, D., Taub, R., Bansal, M., Kowdley, K. V., Younossi, ZM. & Loomba, R., Jan 2024, In: Alimentary Pharmacology and Therapeutics. 59, 1, p. 51-63 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Non-alcoholic Fatty Liver Disease 100%
  • Fatty Liver 99%
  • Liver 20%
  • Biopsy 20%
  • Therapeutics 15%
  8 Scopus citations

• Effect of a Hispanic outreach program on referral and liver transplantation volume at a single center

  Kodali, S., Mobley, C. M., Brombosz, E. W., Lopez, A., Graves, R., Ontiveros, J., Velazquez, M., Saharia, A., Cheah, Y. L., Simon, C. J., Valverde, C., Brown, A., Corkrean, J., Moore, L. W., Graviss, E. A., Victor, D. W., Maresh, K., Hobeika, M. J., Egwim, C. & Ghobrial, R. M., Jun 2024, In: Transplant Immunology. 84, 102034.

  Research output: Contribution to journal › Article › peer-review

  • Hispanic Americans 100%
  • Liver Transplantation 94%
  • Referral and Consultation 76%
  • End Stage Liver Disease 22%
  • Liver Neoplasms 18%

• Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella

  Noureddin, M., Wei, L., Castera, L. & Tsochatzis, E. A., Jan 2024, In: Clinical Gastroenterology and Hepatology. 22, 1, p. 9-11 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly

  Danpanichkul, P., Suparan, K., Ng, C. H., Dejvajara, D., Kongarin, S., Panpradist, N., Chaiyakunapruk, N., Muthiah, M. D., Chen, V. L., Huang, D. Q., Díaz, L. A., Noureddin, M., Arab, J. P. & Wijarnpreecha, K., Apr 2024, In: JHEP Reports. 6, 4, 101020.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Alcoholism 100%
  • Liver Diseases 92%
  • Alcohols 82%
  • Elderly 74%
  • Quality-Adjusted Life Years 28%

• Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis

  Lim, W. H., Tay, P., Ng, C. H., Tan, D. J. H., Ong, C., Koh, J. H., Teng, M., Chee, D., Wong, Z. Y., Kawaguchi, T., Takahashi, H., Muthiah, M., Tan, E. X. X., Wijarnpreecha, K., Lee, G. H., Noureddin, M., Lee, B. P., Mathurin, P., Loomba, R. & Huang, D. Q., Mar 2024, In: Alimentary Pharmacology and Therapeutics. 59, 6, p. 730-741 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Alcohol Abstinence 100%
  • Alcohols 51%
  • Meta-Analysis 51%
  • Fibrosis 51%
  • Cohort Studies 5%

• Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040

  Danpanichkul, P., Ng, C. H., Muthiah, M. D., Duangsonk, K., Kongarin, S., Srisurapanont, K., Pingwang, P., Songmueang, N., Nonthasoot, C., Manosroi, W., Nathisuwan, S., Li, F., Yang, J. D., Chen, V. L., Kim, D., Noureddin, M., Huang, D. Q. & Wijarnpreecha, K., 2024, (Accepted/In press) In: Mayo Clinic Proceedings.

  Research output: Contribution to journal › Article › peer-review

  • Metabolic Syndrome 100%
  • Liver Diseases 91%
  • Obesity 75%
  • Quality-Adjusted Life Years 60%
  • Hypertension 47%

• NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

  Nash Hcc Transplant Collaborative, Jan 2024, In: Clinical Gastroenterology and Hepatology. 22, 1, p. 197-199.e3

  Research output: Contribution to journal › Article › peer-review

  Open Access
  6 Scopus citations

• Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

  Noureddin, M., Truong, E., Mayo, R., Martínez-Arranz, I., Mincholé, I., Banales, J. M., Arrese, M., Cusi, K., Arias-Loste, M. T., Bruha, R., Romero-Gómez, M., Iruzubieta, P., Aller, R., Ampuero, J., Calleja, J. L., Ibañez-Samaniego, L., Aspichueta, P., Martín-Duce, A., Kushner, T., Ortiz, P., & 5 othersHarrison, S. A., Anstee, Q. M., Crespo, J., Mato, J. M. & Sanyal, A. J., Jan 2024, In: Hepatology. 79, 1, p. 135-148 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Metabolomics 100%
  • Fatty Liver 96%
  • Fibrosis 67%
  • Serum 41%
  • Elasticity Imaging Techniques 33%
  8 Scopus citations

• Summary of a consensus conference on heart-liver transplantation

  Consensus Conference participants, Mar 2024, In: American Journal of Transplantation. 24, 3, p. 380-390 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Heart Transplantation 100%
  • Congresses 93%
  • Liver Transplantation 86%
  • Heart 53%
  • Liver Diseases 19%

• The Global Burden of Early-Onset Biliary Tract Cancer: Insight From the Global Burden of Disease Study 2019

  Danpanichkul, P., Ng, C. H., Tan, D. J. H., Muthiah, M. D., Kongarin, S., Srisurapanont, K., Kanjanakot, Y., Duangsonk, K., Huang, D. Q., Suzuki, H., Harnois, D. M., Yang, J. D., Noureddin, M. & Wijarnpreecha, K., Mar 1 2024, In: Journal of Clinical and Experimental Hepatology. 14, 2, p. 101320 101320.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biliary Tract Neoplasms 100%
  • Global Burden of Disease 94%
  • Incidence 34%
  • Quality-Adjusted Life Years 31%
  • Southeastern Asia 17%

• Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? – Authors' reply

  Noureddin, M., Jorkasky, D., Khan, S. & Sanyal, A. J., Feb 2024, In: The Lancet Gastroenterology and Hepatology. 9, 2, p. 105-106 2 p.

  Research output: Contribution to journal › Article › peer-review

• Update on the Screening, Diagnosis, and Management of Cholangiocarcinoma

  Kodali, S., Connor, A. A., Brombosz, E. W. & Ghobrial, R. M., Mar 2024, In: Gastroenterology and Hepatology. 20, 3, p. 151-158 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Cholangiocarcinoma 100%
  • ivosidenib 19%
  • Liver Transplantation 17%
  • durvalumab 16%
  • Yttrium-90 14%
• 2023

  960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

  Abdelrahim, M., Esmail, A., He, A. R., Franses, J., Bhan, I., Victor, III, D. W., Kodali, S., Connor, A. A., Saharia, A., Brdiges, C., Tin, T., Brewer, C., Jurdi, A., Liu, M. C. & Ghobrial, R. M., 2023, In: Annals of Oncology. 34, p. S600

  Research output: Contribution to journal › Article › peer-review

• A global research priority agenda to advance public health responses to fatty liver disease

  Healthy Livers, Healthy Lives Collaborators, Sep 2023, In: Journal of Hepatology. 79, 3, p. 618-634 17 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fatty Liver 100%
  • Liver Diseases 78%
  • Public Health 66%
  • Consensus 44%
  • Global Health 30%
  10 Scopus citations

• An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics

  Serafini, E., Corti, A., Gallo, D., Chiastra, C., Li, X. C. & Casarin, S., 2023, In: Frontiers in Bioengineering and Biotechnology. 11, p. 1190409 1190409.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Shear Stress 100%
  • Allografts 73%
  • Hemodynamic 41%
  • Cell Activity 38%
  • Thickening 34%
  1 Scopus citations

• An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

  LITMUS Consortium Investigators, Sep 2023, In: Journal of Hepatology. 79, 3, p. 592-604 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Elasticity Imaging Techniques 100%
  • Non-alcoholic Fatty Liver Disease 88%
  • Data Analysis 61%
  • Meta-Analysis 61%
  • Fibrosis 61%
  6 Scopus citations

• An uncommon cause of a giant abdominal mass

  Tellez-Garcia, E. & Saharia, A., 2023, In: Gastroenterology and Hepatology from Bed to Bench. 16, 1, p. 539-541 3 p.

  Research output: Contribution to journal › Article › peer-review

• A scientifically validated combination of garcinol, curcuminoids, and piperine for mild to moderate nonalcoholic steatohepatitis patients—results from a randomized, double-blind, placebo-controlled study

  Majeed, M., Nagabhushanam, K., Noureddin, M., Paulose, S., Barik, C., Saklecha, S. & Mundkur, L., 2023, In: Frontiers in Nutrition. 10, 1201186.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • garcinol 100%
  • piperine 84%
  • Diarylheptanoids 84%
  • placebos 59%
  • Non-alcoholic Fatty Liver Disease 58%

• ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma

  Swords, D. S., Newhook, T. E., Tzeng, C. W. D., Massarweh, N. N., Chun, Y. S., Lee, S., Kaseb, A. O., Ghobrial, M., Vauthey, J. N. & Tran Cao, H. S., Dec 1 2023, In: Annals of Surgical Oncology. 30, 13, p. 8019-8020 2 p.

  Research output: Contribution to journal › Article › peer-review

• Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

  Collaborative Islet Transplant Registry (CITR) Investigators study group, Jun 2023, In: The Lancet Diabetes and Endocrinology. 11, 6, p. 391-401 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Islets of Langerhans Transplantation 100%
  • Homologous Transplantation 87%
  • Type 1 Diabetes Mellitus 69%
  • Registries 61%
  • Observational Studies 60%
  7 Scopus citations

• Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

  The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E39

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Genome 100%
  • Neoplasms 47%
  1 Scopus citations

• Caring for the Liver: Updates on Global Prevalence, Cutting-Edge Diagnosis, and State-of-the-Art Management for Researchers and Clinicians, 2023 and Beyond

  Castera, L., Noureddin, M., Wei, L. & Kahi, C., Jul 2023, In: Clinical Gastroenterology and Hepatology. 21, 8, p. 1975-1977 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients

  Long, J. J., Motter, J. D., Jackson, K. R., Chen, J., Orandi, B. J., Montgomery, R. A., Stegall, M. D., Jordan, S. C., Benedetti, E., Dunn, T. B., Ratner, L. E., Kapur, S., Pelletier, R. P., Roberts, J. P., Melcher, M. L., Singh, P., Sudan, D. L., Posner, M. P., El-Amm, J. M., Shapiro, R., & 23 othersCooper, M., Verbesey, J. E., Lipkowitz, G. S., Rees, M. A., Marsh, C. L., Sankari, B. R., Gerber, D. A., Wellen, J. R., Bozorgzadeh, A., Gaber, A. O., Heher, E. C., Weng, F. L., Djamali, A., Helderman, J. H., Concepcion, B. P., Brayman, K. L., Oberholzer, J., Kozlowski, T., Covarrubias, K., Massie, A. B., McAdams-DeMarco, M. A., Segev, D. L. & Garonzik-Wang, J. M., Dec 2023, In: American Journal of Transplantation. 23, 12, p. 1980-1989 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Living Donors 100%
  • HLA Antigens 91%
  • Kidney Transplantation 84%
  • Transplants 50%
  • Transplant Recipients 49%

• Combined liver transplantation and sleeve gastrectomy: Report of a brief-interval staged approach

  Tariq, N., Saharia, A., Nwokedi, U., Hobeika, M. J., Mobley, C. M., Hsu, D., Potter, L. M., Moore, L. W., Elaileh, A., Sherman, V. & Ghobrial, R. M., Apr 2023, In: Liver Transplantation. 29, 4, p. 422-430 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy 100%
  • Liver Transplantation 88%
  • End Stage Liver Disease 38%
  • Weight Loss 26%
  • Bariatric Surgery 23%
  2 Scopus citations

• Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)

  Subuddhi, A., Uosef, A., Zou, D., Ubelaker, H. V., Ghobrial, R. M. & Kloc, M., May 1 2023, In: International Immunopharmacology. 118, p. 110017 110017.

  Research output: Contribution to journal › Article › peer-review

  • Fingolimod Hydrochloride 100%
  • Y 27632 98%
  • Transcriptome 66%
  • Macrophages 50%
  • Transplantation 27%

• Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography

  Xiao, J., Ng, C. H., Chan, K. E., Tang, A. S. P., Teh, R., Ling, A. H. Z., Yong, J. N., Lim, W. H., Tan, D. J. H., Tan, C., Win, K. M., Bwa, A. H., Chew, N. W. S., Huang, D., Dan, Y. Y., Noureddin, M., Siddiqui, M. S., Sanyal, A., Tamaki, N. & Muthiah, M., 2023, In: Scandinavian Journal of Gastroenterology. 58, 1, p. 76-82 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Alcohol Abstinence 100%
  • Elasticity Imaging Techniques 84%
  • Non-alcoholic Fatty Liver Disease 74%
  • Population 27%
  • Alcohol Drinking 25%

• Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8⁺ T Cell Immunity against Tumor

  Yu, A., Fu, J., Yin, Z., Yan, H., Xiao, X., Zou, D., Zhang, X., Zu, X., Li, X. C. & Chen, W., Nov 2023, In: Research. 6, 0271.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • interferon regulatory factor-4 100%
  • Immunity 47%
  • Tumor-Infiltrating Lymphocytes 37%
  • T-Lymphocytes 36%
  • Cell- and Tissue-Based Therapy 34%

• Deceased donor vein extension grafts for right living donor kidney transplantation

  Meinders, A. M., Knight, R., Eagar, T. N., Hobeika, M., Podder, H., Gaber, A. O. & Yi, S. G., Aug 2023, In: Clinical Transplantation. 37, 8, e14963.

  Research output: Contribution to journal › Article › peer-review

  • Living Donors 100%
  • Kidney Transplantation 84%
  • Veins 74%
  • Tissue Donors 69%
  • Transplants 55%

• Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium

  Tran, B. V., Moris, D., Markovic, D., Zaribafzadeh, H., Henao, R., Lai, Q., Florman, S. S., Tabrizian, P., Haydel, B., Ruiz, R. M., Klintmalm, G. B., Lee, D. D., Taner, C. B., Hoteit, M., Levine, M. H., Cillo, U., Vitale, A., Verna, E. C., Halazun, K. J., Tevar, A. D., & 29 othersHumar, A., Chapman, W. C., Vachharajani, N., Aucejo, F., Lerut, J., Ciccarelli, O., Nguyen, M. H., Melcher, M. L., Viveiros, A., Schaefer, B., Hoppe-Lotichius, M., Mittler, J., Nydam, T. L., Markmann, J. F., Rossi, M., Mobley, C., Ghobrial, M., Langnas, A. N., Carney, C. A., Berumen, J., Schnickel, G. T., Sudan, D. L., Hong, J. C., Rana, A., Jones, C. M., Fishbein, T. M., Busuttil, R. W., Barbas, A. S. & Agopian, V. G., Jul 2023, In: Liver Transplantation. 29, 7, p. 683-697 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Liver Neoplasms 100%
  • Liver Transplantation 91%
  • Hepatocellular Carcinoma 80%
  • Transplants 62%
  • Recurrence 47%
  4 Scopus citations

• Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US

  Lim, W. H., Yong, J. N., Ong, C. E. Y., Ng, C. H., Tan, D. J. H., Zeng, R. W., Chung, C. H., Kaewdech, A., Chee, D., Tseng, M., Wijarnpreecha, K., Syn, N., Bonney, G. K., Kow, A., Huang, D. Q., Noureddin, M., Muthiah, M., Tan, E. & Siddiqui, M. S., Nov 1 2023, In: Liver Transplantation. 29, 11, p. 1181-1191 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Non-alcoholic Fatty Liver Disease 100%
  • European Continental Ancestry Group 86%
  • Liver Transplantation 84%
  • Hispanic Americans 71%
  • End Stage Liver Disease 65%
  1 Scopus citations

• Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

  Wang, Z., Kim, S. Y., Tu, W., Kim, J., Xu, A., Yang, Y. M., Matsuda, M., Reolizo, L., Tsuchiya, T., Billet, S., Gangi, A., Noureddin, M., Falk, B. A., Kim, S., Fan, W., Tighiouart, M., You, S., Lewis, M. S., Pandol, S. J., Di Vizio, D., & 5 othersMerchant, A., Posadas, E. M., Bhowmick, N. A., Lu, S. C. & Seki, E., Jul 11 2023, In: Cell Metabolism. 35, 7, p. 1209-1226.e13

  Research output: Contribution to journal › Article › peer-review

  • Extracellular Vesicles 100%
  • Fatty Liver 90%
  • Tumor Microenvironment 88%
  • Liver Neoplasms 70%
  • Colorectal Neoplasms 56%
  10 Scopus citations

• Factors affecting survival after liver retransplantation: a systematic review and meta-analysis

  Brombosz, E. W., Moore, L. W., Mobley, C. M., Kodali, S., Saharia, A., Hobeika, M. J., Connor, A. A., Victor, III, D. W., Cheah, Y. L., Simon, C. J., Gaber, A. O. & Ghobrial, R. M., May 31 2023, In: Frontiers in Transplantation. 2, p. 1181770 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Meta-Analysis 100%
  • Systematic Reviews 98%
  • Survival 74%
  • Liver 69%
  • Cold Ischemia 58%

• Gasdermin D-mediated pyroptosis is regulated by AMPK-mediated phosphorylation in tumor cells

  Chu, X., Xiao, X., Wang, G., Uosef, A., Lou, X., Arnold, P., Wang, Y., Kong, G., Wen, M., Minze, L. J. & Li, X. C., Jul 2023, In: Cell Death and Disease. 14, 7, 469.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pyroptosis 100%
  • AMP-Activated Protein Kinases 90%
  • Phosphorylation 52%
  • Neoplasms 24%
  • AMP-activated protein kinase kinase 18%
  1 Scopus citations

• Gemcitabine Plus Cisplatin versus Non-gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.

  Abdelrahim, M., Esmail, A., Xu, J., Umoru, G., Saharia, A. & Ghobrial, R. M., 2023, In: HPB. 25, p. S223

  Research output: Contribution to journal › Article › peer-review

• Graft-resident donor macrophages functionally regulate transplant outcomes

  Su, X. & Li, X. C., Apr 2023, In: American Journal of Transplantation. 23, 4, p. 455-456 2 p.

  Research output: Contribution to journal › Article › peer-review

• Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma

  Yeo, Y. H., Liang, J., Lauzon, M., Luu, M., Noureddin, M., Ayoub, W., Kuo, A., Sankar, K., Gong, J., Hendifar, A., Osipov, A., Friedman, M. L., Gabriel Lipshutz, H., Steinberger, J., Kosari, K., Nissen, N., Abou-Alfa, G. K., Singal, A. G. & Yang, J. D., Dec 1 2023, In: American Journal of Gastroenterology. 118, 12, p. 2201-2211 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunotherapy 100%
  • Hepatocellular Carcinoma 91%
  • Survival 20%
  • Therapeutics 18%
  • Propensity Score 13%
  1 Scopus citations

• Impact of pre-operative transjugular intrahepatic portosystemic shunt on post-operative outcomes following non-transplant surgeries in patients with decompensated cirrhosis

  Patel, P., Irani, M., Graviss, E. A., Nguyen, D. T., Quigley, E. M. M. & Victor, D. W., Jan 25 2023, In: Translational Gastroenterology and Hepatology. 8, p. 9 9.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transjugular Intrahepatic Portasystemic Shunt 100%
  • Fibrosis 53%
  • Mortality 20%
  • Ascites 15%
  • Surgical Portasystemic Shunt 11%

• Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation

  Mysore, K. R., Kannanganat, S., Schraw, J. M., Lupo, P. J., Goss, J. A., Setchell, K. D. R., Kheradmand, F., Li, X. C. & Shneider, B. L., Jan 2023, In: American Journal of Transplantation. 23, 1, p. 26-36 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Liver Diseases 100%
  • Transplantation 90%
  • Chronic Disease 87%
  • Inflammation 69%
  • Monocytes 56%

• Interleukin-2 and PD-1 synergistically modify T cell exhaustion programs

  Cravedi, P. & Li, X. C., Feb 2023, In: American Journal of Transplantation. 23, 2, p. 161-162 2 p.

  Research output: Contribution to journal › Article › peer-review

• Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant

  Vincenti, F., Bestard, O., Brar, A., Cruzado, J. M., Seron, D., Gaber, A. O., Ali, N., Tambur, A. R., Lee, H., Abbadessa, G., Paul, J-A., Dudek, M., Siegel, R. J., Torija, A., Semiond, D., Lépine, L., Ternes, N., Montgomery, R. A. & Stegall, M., Dec 26 2023, (E-pub ahead of print) In: Journal of the American Society of Nephrology.

  Research output: Contribution to journal › Article › peer-review

  • isatuximab 100%
  • Transplants 30%
  • Antibodies 26%
  • Kidney 25%
  • Plasma Cells 16%

• Longitudinal estimated glomerular filtration rate (eGFR) modeling in long-term renal function to inform clinical trial design in kidney transplantation

  Kosinski, L., Frey, E., Klein, A., O'Doherty, I., Romero, K., Stegall, M., Helanterä, I., Gaber, A. O., Fitzsimmons, W. E. & Aggarwal, V., Sep 2023, In: Clinical and Translational Science. 16, 9, p. 1680-1690 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Glomerular Filtration Rate 100%
  • Kidney Transplantation 99%
  • Filtration 90%
  • Clinical Trials 68%
  • Kidney 56%

• Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study

  Kim, B. K., Bergstrom, J., Loomba, R., Tamaki, N., Izumi, N., Nakajima, A., Idilman, R., Gumussoy, M., Oz, D. K., Erden, A., Truong, E., Yang, J. D., Noureddin, M., Allen, A. M., Loomba, R. & Ajmera, V., Dec 2023, In: Hepatology. 78, 6, p. 1858-1866 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Elasticity Imaging Techniques 100%
  • Non-alcoholic Fatty Liver Disease 88%
  • Multicenter Studies 71%
  • Cohort Studies 56%
  • Liver 42%
  2 Scopus citations

• Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference

  Kirchner, V. A., Shankar, S., Victor, D. W., Tanaka, T., Goldaracena, N., Troisi, R. I., Olthoff, K. M., Kim, J. M., Pomfret, E. A., Heaton, N., Polak, W. G., Shukla, A., Mohanka, R., Balci, D., Ghobrial, M., Gupta, S., Maluf, D., Fung, J. J., Eguchi, S., Roberts, J., & 19 othersEghtesad, B., Selzner, M., Prasad, R., Kasahara, M., Egawa, H., Lerut, J., Broering, D., Berenguer, M., Cattral, M. S., Clavien, P. A., Chen, C. L., Shah, S. R., Zhu, Z. J., Ascher, N., Ikegami, T., Bhangui, P., Rammohan, A., Emond, J. C. & Rela, M., Oct 1 2023, In: Transplantation. 107, 10, p. 2238-2246 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Living Donors 100%
  • Liver Transplantation 80%
  • Guidelines 57%
  • Transplants 55%
  • Interventional Radiology 42%